STE peers and competitors
STERIS plc · end-of-day data as of Oct 16, 2026
STERIS plc
$222.66+4.3%
Buy · 9 analystsPT $276.53 +24.2%
STE’s peers by industry and size include DexCom (DXCM), GE HealthCare Technologies (GEHC) and Alnylam Pharmaceuticals (ALNY). Among these 12 companies STE ranks 8th by market cap ($21.71B); its P/E of 27.2 compares with a median of 25.6 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 2 |  | $69.57 | -1.1% | -21.0% | +20.2% | 20.2 | $31.42B | |
| 3 |  | $231.83 | -0.9% | -52.8% | +61.5% | 39.2 | $31.02B | |
| 4 |  | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | |
| 5 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 6 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B | |
| 7 |  | $113.07 | -0.2% | -13.0% | +13.6% | 14.4 | $22.92B | |
| 8 | | $222.66 | -0.7% | -16.4% | +24.2% | 27.2 | $21.71B | |
| 9 |  | $18.66 | +2.4% | 0.0% | +9.8% | — | $21.43B | |
| 10 |  | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | |
| 11 |  | $152.64 | -1.3% | -3.0% | -18.2% | 72.7 | $17.03B | |
| 12 |  | $85.81 | -2.3% | -7.2% | +3.6% | 10.5 | $14.61B |
Data as of Oct 16, 2026 close.